UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2023 (FY2024), from USAspending.gov. UEI: MSPWVMXXMN76
20contracts won
$25,611,015total obligated
$1,030,071median contract
Sep 15, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 16 | $24,132,327 |
| Department of Defense | 4 | $1,478,687 |
Industries (NAICS)
| NAICS | Contracts | Obligated |
|---|---|---|
| 541711 Research and development in biotechnology | 8 | $12,130,135 |
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 6 | $8,686,322 |
| 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 4 | $4,625,993 |
| 611310 Colleges, Universities, and Professional Schools | 2 | $168,564 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| EVALUATION OF THERAPEUTICS AND VACCINES IN MOUSE MODELS OF DENGUE VIRUS.
75N93026F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$844,795 Potential value: $5,329,933 |
Sep 15, 2026 Ends: Sep 14, 2027 |
| TASK A28 - SYRIAN GOLDEN HAMSTER MODEL FOR TESTING MEDICAL COUNTERMEASURES (MCM) AGAINST NIPAH VIRUS (NIV)
75N93026F00003 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$1,330,980 Potential value: $5,699,112 |
Sep 01, 2026 Ends: Aug 31, 2027 |
| SCREENING CANDIDATE COUNTERMEASURES FOR VIRAL HEMORRHAGIC FEVER USING LIVER-BASED ORGAN-ON-A-CHIP MICROPHYSIOLOGICAL SYSTEMS (MPS) IN HIGH-L…
75N93026F00002 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$1,388,934 Potential value: $6,285,771 |
Jul 27, 2026 Ends: Jul 26, 2027 |
| RESEARCH SUPPORT EXPERTISE REGARDING THE PRECLINICAL DEVELOPMENT OF CAP-DEPENDENT ENDONUCLEASE INHIBITORS (CENIS) WITH VIRUSES THAT REQUIRE …
N0018926PB026 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Galveston, TX |
— | Department of Defense Department of the Navy |
$204,095 Potential value: $794,077 |
Jun 24, 2026 Ends: Jun 23, 2027 |
| MOUSE AND GUINEA PIG MODELS FOR CYTOMEGALOVIRUS AND HERPES SIMPLEX VIRUSES
75N93025F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$2,343,311 Potential value: $3,650,793 |
Sep 15, 2025 Ends: Sep 14, 2027 |
| TUITION AND FEES TX, UNIVERSITY OF TEXAS MEDICAL BRANCH @ GALVESTON AY 1301282656
N0622A25FA537 · NAICS 611310 Colleges, Universities, and Professional Schools · Galveston, TX |
— | Department of Defense Department of the Navy |
$59,873 | Sep 02, 2025 Ends: Jun 30, 2026 |
| TASK A02 - UNIVERSITY OF TEXAS MEDICAL BRANCH (UTMB)
75N93024F00006 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$2,603,774 Potential value: $5,130,964 |
Sep 20, 2024 Ends: Feb 17, 2027 |
| THE CONTRACTOR SHALL EXTRACT HISTORICAL RAW DATA FROM ALL STUDIES PERFORMED UNDER PERFORMED UNDER PREVIOUS IDIQ CONTRACT MECHANISMS
75N93024F00005 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$174,528 | Aug 30, 2024 Ends: Jul 14, 2031 |
| MODEL DEVELOPMENT AND MEDICAL COUNTER MEASURES (MCMS) FOR BSL-4 AGENTS IN NHPS.
75N93024F00002 · NAICS 541711 Research and development in biotechnology · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$3,270,971 Potential value: $6,739,837 |
Jun 25, 2024 Ends: Jan 17, 2027 |
| TUITION AND FEES
N0622A24F00LA · NAICS 611310 Colleges, Universities, and Professional Schools · Galveston, TX |
— | Department of Defense Department of the Navy |
$108,691 | Jun 03, 2024 Ends: Jun 30, 2025 |
| PRECLINICAL MODELS OF INFECTIOUS DISEASES
75N93024F00001 · NAICS 541711 Research and development in biotechnology · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$1,199,853 Potential value: $1,745,363 |
Apr 15, 2024 Ends: Apr 14, 2026 |
| THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOL…
75N95023C00016 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Rockville, MD |
— | Department of Health and Human Services National Institutes of Health |
$2,527,425 Potential value: $9,694,843 |
Aug 23, 2023 Ends: Aug 22, 2027 |
| TESTING OF A NOVEL INHALED CLOFAZIMINE (CFZ) DRY POWDER FORMULATION IN A MOUSE MODEL OF MYCOBACTERIUM TUBERCULOSIS
75N93023F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$788,445 | Aug 01, 2023 Ends: Sep 30, 2025 |
| ADVANCING HUMAN LUNG MICROPHYSIOLOGICAL SYSTEMS TO MODEL CORONAVIRUS INFECTION AND TEST CANDIDATE COUNTERMEASURES
75N93022F00006 · NAICS 541711 Research and development in biotechnology · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$1,848,326 | Sep 12, 2022 Ends: May 16, 2025 |
| EFFICACY TESTING OF INTRALYTIX BACTERIOPHAGE COCKTAIL WITH IN VITRO ACTIVITY AGAINST Y. PESTIS, IN RAT PLAGUE MODEL
75N93022F00004 · NAICS 541711 Research and development in biotechnology · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$513,687 | Jun 10, 2022 Ends: Jul 13, 2024 |
| PRECLINICAL MODELS OF INFECTIOUS DISEASES
75N93022F00002 · NAICS 541711 Research and development in biotechnology · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$811,973 Potential value: $1,151,741 |
Feb 10, 2022 Ends: Apr 12, 2024 |
| ISSUE TASK ORDER A63
75N93022F00001 · NAICS 541711 Research and development in biotechnology · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$2,676,543 Potential value: $5,848,314 |
Nov 02, 2021 Ends: Jan 11, 2025 |
| TO ISSUE PCMID B13 TASK ORDER AWARD
75N93021F00001 · NAICS 541711 Research and development in biotechnology · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$954,114 | Sep 24, 2021 Ends: Oct 20, 2023 |
| PCMID IDIQ
75N93020F00004 · NAICS 541711 Research and development in biotechnology · Galveston, TX |
— | Department of Health and Human Services National Institutes of Health |
$854,669 | Jul 17, 2020 Ends: Jul 13, 2024 |
| BA160657-SMART OXYGENATION SYSTEM (SOS)
W81XWH18C0156 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Galveston, TX |
— | Department of Defense Department of the Army |
$1,106,028 | Aug 31, 2018 Ends: Nov 30, 2023 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.